WebJan 10, 2024 · The upgrade of Dyne Therapeutics, Inc. to a Zacks Rank #1 positions it in the top 5% of the Zacks-covered stocks in terms of estimate revisions, implying that the stock might move higher in the ... WebDyne Therapeutics, Inc., a muscle disease company, operates as a biotechnology company that focuses on advancing therapeutics for genetically driven muscle diseases in the United States. It develops various programs for myotonic dystrophy type 1, duchenne muscular dystrophy, and facioscapulohumeral dystrophy, as well as rare skeletal muscle ...
Dyne Therapeutics (DYN) Stock Price & Analysis - TipRanks
WebApr 11, 2024 · A high-level overview of Dyne Therapeutics, Inc. (DYN) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and … WebDYN Stock 12 Months Forecast. Based on 4 Wall Street analysts offering 12 month price targets for Dyne Therapeutics in the last 3 months. The average price target is $28.50 with a high forecast of $34.00 and a low forecast of $20.00. The average price target represents a 155.61% change from the last price of $11.15. on the buses bus
Dyne Therapeutics, Inc. (NASDAQ:DYN) Receives Consensus …
WebARF Manager. Genocea Biosciences. Sep 2024 - Feb 20243 years 6 months. Cambridge, MA. WebDYN stock forecast Our latest prediction for Dyne Therapeutics Inc's stock price was made on the Dec. 15, 2024 when the stock price was at 13.59$.. In the short term (2weeks), DYN's stock price should underperform the market by -4.52%.During that period the price should oscillate between -12.37% and +6.64%.. In the medium term (3months), DYN's … WebGet the latest Dyne Therapeutics Inc (DYN) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and … on the buses clippies